The assessment appears to be like on the presence of authorised and unauthorised pharmacologically lively substances and their residues in meals. The info within the 2023 report got here from the EU Member States[1], plus Iceland and Norway.
In 2023, the share of non-compliant samples was 0.11% (602 of 548,194 samples) general.
This report is the primary to function a revised division of the samples below three plans:
- Nationwide risk-based management plan for manufacturing within the Member States – 0.15% non-compliance
- Nationwide randomised surveillance plan – 0.29% non-compliance
- Nationwide risk-based management plan for third-country imports – 0.23% non-compliance.
EFSA’s report helps danger managers within the European Fee and in Member States to guage the effectiveness of management plans on pharmacologically lively substances and their residues in limiting the presence of those substance teams within the EU meals chain. It additionally helps decide observe up measures to additional scale back non-compliance in subsequent years.
Discover the ends in higher element utilizing our interactive dashboard and an information visualisation.
- Report for 2023 on the outcomes from the monitoring of veterinary medicinal product residues and different substances in stay animals and animal merchandise
